Similar articles

• Prostaglandin E1 reduces myocardial reperfusion injury by inhibiting proinflammatory cytokines production during cardiac surgery.

  Kawamura T, Nara N, Kadosaki M, Inada K, Endo S. Kawamura T, et al. Crit Care Med. 2000 Jul;28(7):2201-8. doi: 10.1097/00003246-200007000-00004. Crit Care Med. 2000. PMID: 10921541 Clinical Trial.
• Myocardial injury and protection related to cardiopulmonary bypass.

  De Hert S, Moerman A. De Hert S, et al. Best Pract Res Clin Anaesthesiol. 2015 Jun;29(2):137-49. doi: 10.1016/j.bpa.2015.03.002. Epub 2015 Mar 27. Best Pract Res Clin Anaesthesiol. 2015. PMID: 26060026 Review.
• Cytokines in myocardial injury: impact on cardiac surgical approach.

  Wan S, Yim AP. Wan S, et al. Eur J Cardiothorac Surg. 1999 Sep;16 Suppl 1:S107-11. doi: 10.1016/s1010-7940(99)00200-6. Eur J Cardiothorac Surg. 1999. PMID: 10536961 Review.
• Deep hypothermic circulatory arrest and global reperfusion injury: avoidance by making a pump prime reperfusate--a new concept.

  Allen BS, Veluz JS, Buckberg GD, Aeberhard E, Ignarro LJ. Allen BS, et al. J Thorac Cardiovasc Surg. 2003 Mar;125(3):625-32. doi: 10.1067/mtc.2003.96. J Thorac Cardiovasc Surg. 2003. PMID: 12658205
• Thrombin in myocardial ischemia-reperfusion during cardiac surgery.

  Raivio P, Lassila R, Petäjä J. Raivio P, et al. Ann Thorac Surg. 2009 Jul;88(1):318-25. doi: 10.1016/j.athoracsur.2008.12.097. Ann Thorac Surg. 2009. PMID: 19559265 Review.